Sabari Nath Neerukonda

us food & drug administration (fda)

H指数:18

被引数:1,073

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site

PLOS PATHOGENS

IF4.9

2025-04-010

OAAI

Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes

MICROBIOLOGY SPECTRUM

IF3.8

2025-01-280

SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

VIRUSES-BASEL

IF3.5

2023-06-304

OAAI

SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City

纽约市野生白尾鹿的SARS-CoV-2 Omicron (B.1.1.529) 感染

VIRUSES-BASEL

IF3.5

2022-12-1220

OAAI

Vandegrift, Kurt J.; Yon, Michele; Surendran Nair, Meera; Gontu, Abhinay; Ramasamy, Santhamani; Amirthalingam, Saranya; Neerukonda, Sabarinath; Nissly, Ruth H.; Chothe, Shubhada K.; Jakka, Padmaja; LaBella, Lindsey; Levine, Nicole; Rodriguez, Sophie; Chen, Chen; Sheersh Boorla, Veda; Stuber, Tod; Boulanger, Jason R.; Kotschwar, Nathan; Aucoin, Sarah Grimke; Simon, Richard; Toal, Katrina L.; Olsen, Randall J.; Davis, James J.; Bold, Dashzeveg; Gaudreault, Natasha N.; Dinali Perera, Krishani; Kim, Yunjeong; Chang, Kyeong-Ok; Maranas, Costas D.; Richt, Juergen A.; Musser, James M.; Hudson, Peter J.; Kapur, Vivek; Kuchipudi, Suresh V.

Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants

Omicron BA.1，BA.1.1，BA.2和BA.3变体的进入途径，确定进入的物种特异性血管紧张素转换酶2残基以及抗体中和逃避的特征

JOURNAL OF VIROLOGY

IF3.8

2022-09-1416

OAAI

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

NATURE BIOTECHNOLOGY

IF41.7

2022-07-2136

OAAI

Rothenberger, Sylvia; Hurdiss, Daniel L.; Walser, Marcel; Malvezzi, Francesca; Mayor, Jennifer; Ryter, Sarah; Moreno, Hector; Liechti, Nicole; Bosshart, Andreas; Iss, Chloe; Calabro, Valerie; Cornelius, Andreas; Hospodarsch, Tanja; Neculcea, Alexandra; Looser, Thamar; Schlegel, Anja; Fontaine, Simon; Villemagne, Denis; Paladino, Maria; Schiegg, Dieter; Mangold, Susanne; Reichen, Christian; Radom, Filip; Kaufmann, Yvonne; Schaible, Doris; Schlegel, Iris; Zitt, Christof; Sigrist, Gabriel; Straumann, Marcel; Wolter, Julia; Comby, Marco; Sacarcelik, Feyza; Drulyte, Ieva; Lyoo, Heyrhyoung; Wang, Chunyan; Li, Wentao; Du, Wenjuan; Binz, H. Kaspar; Herrup, Rachel; Lusvarghi, Sabrina; Neerukonda, Sabari Nath; Vassell, Russell; Wang, Wei; Adler, Julia M.; Eschke, Kathrin; Nascimento, Mariana; Abdelgawad, Azza; Gruber, Achim D.; Bushe, Judith; Kershaw, Olivia; Knutson, Charles G.; Balavenkatraman, Kamal K.; Ramanathan, Krishnan; Wyler, Emanuel; Alves, Luiz Gustavo Teixeira; Lewis, Seth; Watson, Randall; Haeuptle, Micha A.; Zuercher, Alexander; Dawson, Keith M.; Steiner, Daniel; Weiss, Carol D.; Amstutz, Patrick; van Kuppeveld, Frank J. M.; Stumpp, Michael T.; Bosch, Berend-Jan; Engler, Olivier; Trimpert, Jakob

Development and Validation of Indirect Enzyme-Linked Immunosorbent Assays for Detecting Antibodies to SARS-CoV-2 in Cattle, Swine, and Chicken

VIRUSES-BASEL

IF3.5

2022-06-223

OAAI

Gontu, Abhinay; Marlin, Erika A.; Ramasamy, Santhamani; Neerukonda, Sabarinath; Anil, Gayatri; Morgan, Jasmine; Quraishi, Meysoon; Chen, Chen; Boorla, Veda Sheersh; Nissly, Ruth H.; Jakka, Padmaja; Chothe, Shubhada K.; Ravichandran, Abirami; Kodali, Nishitha; Amirthalingam, Saranya; LaBella, Lindsey; Kelly, Kathleen; Natesan, Pazhanivel; Minns, Allen M.; Rossi, Randall M.; Werner, Jacob R.; Hovingh, Ernest; Lindner, Scott E.; Tewari, Deepanker; Kapur, Vivek; Vandegrift, Kurt J.; Maranas, Costas D.; Nair, Meera Surendran; Kuchipudi, Suresh, V

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2022-05-1871

OAAI

Lusvarghi, Sabrina; Pollett, Simon D.; Neerukonda, Sabari Nath; Wang, Wei; Wang, Richard; Vassell, Russell; Epsi, Nusrat J.; Fries, Anthony C.; Agan, Brian K.; Lindholm, David A.; Colombo, Christopher J.; Mody, Rupal; Ewers, Evan C.; Lalani, Tahaniyat; Ganesan, Anuradha; Goguet, Emilie; Hollis-Perry, Monique; Coggins, Si'Ana A.; Simons, Mark P.; Katzelnick, Leah C.; Wang, Gregory; Tribble, David R.; Bentley, Lisa; Eakin, Ann E.; Broder, Christopher C.; Erlandson, Karl J.; Laing, Eric D.; Burgess, Timothy H.; Mitre, Edward; Weiss, Carol D.

Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects

JOURNAL OF VIROLOGY

IF3.8

2022-01-1224

OAAI

SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity

VIRUSES-BASEL

IF3.5

2021-12-1122

OAAI

A comparison of exosome purification methods using serum of Marek's disease virus (MDV)-vaccinated and -tumor-bearing chickens

HELIYON